Programme - PROSCA 2019 - Global Congress on Prostate Cancer

Scientific
programme

Day 1 – Wednesday 23 October 2019

08:30
Opening exhibition & welcome coffee
09:00
Official opening: the road to Paris

Alberto Bossi – Karim Fizazi

09:20
Diagnosing prostate cancer: MRI first… and then?

Chair: Johan Stranne – Anthony Zietman

09:20

Case-based debate
Wouter Everaerts – Anwar Padhani

10:20
Role of chemotherapy in high-risk localised prostate cancer & mCRPC

Amit Bahl

10:40
Coffee break & interactive poster viewing
11:10
Changing treatment landscape in metastatic hormone-sensitive prostate cancer

Chair: Mack Roach – Bertrand Tombal

11:10

Local therapy of the primary in metastatic disease
Thomas Zilli

11:25

Update on systemic therapy
Karim Fizazi

11:45

Case-based debate

12:05

Q&A

12:30
Lunch break & interactive poster viewing
13:25
Welcome afternoon – day 1

Bertrand Tombal

13:30
The risk of cardiovascular-related events among patients with prostate cancer receiving ADT:
are all drugs created equal?

David Margel

13:50
Management of CRPC in clinical practice

Chair: Amit Bahl – Jeroen van Moorselaar

13:50

nmCRPC: to treat or not to treat?
Karim Fizazi

14:10

Management of mCRPC patients: implications for current clinical practice
Bertrand Tombal

14:30

New agents in mCRPC: a glimpse into the near future
Petros Grivas

14:50

Q&A

15:20
Coffee break & interactive poster viewing
15:50
Expert recommendations from APCCC2019 translated into practice

Aurelius Omlin

16:15
Localised prostate cancer: guidance for daily practice

Chair: Alberto Bossi – Vincent Khoo

16:15

Practical neuro anatomy for prostate cancer treatment
Ash Tewari

16:30

Lymphadenectomy at the time of radical prostatectomy
Derya Tilki

16:45

Active surveillance in 2019
Johan Stranne

17:00

Q&A

]
17:30
Close day 1

Day 2 – Thursday 24 October 2019

08:00
Opening exhibition & welcome coffee
08:25
Welcome morning – day 2

Piet Ost

08:30
Biochemical recurrence after radical therapy: what’s next?

Chair: Nicolas Mottet – Piet Ost

08:30

Impact of imaging on treatment plan
Mack Roach

08:50

Case-based debate
Mack Roach – Derya Tilki

09:45
PSA screening: where do we stand in 2019?

Nicolas Mottet

10:15
Coffee break & interactive poster viewing
10:45
It’s quiz time: The Prostate Challenge
11:05
Oligometastatic prostate cancer: what do we know?

Chair: Wouter Everaerts – Aurelius Omlin

11:05

Case-based debate

11:15

Shaping the definition with Next Generation Imaging
Anwar Padhani

11:30

Management of de novo oligometastatic PCa
Vincent Khoo

11:45

Management of oligorecurrent PCa
Piet Ost

12:00

Q&A

12:30
Lunch break & interactive poster viewing
13:25
Welcome afternoon – day 2

Amit Bahl

13:30
Genetics in PCa: a practical guide for the clinician

Chair: Amit Bahl

13:30

Genetics in PCa: a practical guide for the clinician
Ash Tewari

13:50

Q&A

14:00
Managing high-risk non-metastatic prostate cancer

Chair: Derya Tilki – Thomas Zilli

14:00

Case-based debate

14:10

Bad prognosticators
Eva Comperat

14:20

Multimodality therapy
Jeroen van Moorselaar

14:35

Is brachytherapy essential?
Peter Hoskin

14:50

Q&A

15:15
Coffee break & interactive poster viewing
15:45
Best poster session

Chair: Amit Bahl – Alberto Bossi
Up to 3 case reports or clinical data presented by delegates and commented by expert panel

15:45

Discussions

16:15

Award ceremony and Q&A

16:30
Can biomarkers guide us in the treatment of metastatic prostate cancer?

Chair: Piet Ost

16:30

Can biomarkers guide us in the treatment of metastatic prostate cancer?
Henrik Grönberg

16:50

Q&A

17:00
Keynote lecture (for PROSCA & BLADDR participants)

Chair: Alberto Bossi

17:00

Fabrication, falsehood & plagiarism: the unholy trinity of scientific misbehaviour
Anthony Zietman

17:20

Q&A

]
17:30
Close PROSCA

Amit Bahl – Piet Ost – Ash Tewari

17:35
Networking reception for PROSCA & BLADDR participants
Legend:
Lecture
Debate/ panel discussion
Q&A

Cité Internationale Universitaire de Paris

Mirrors of Medicine

Organised by
ISSECAM

Congress management by
e-HIMS

Endorsed by ESTRO